ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,221Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 2170

$1.34M Total Retail Price of All Prescriptions

Rank: 27 out of 2170

436 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 15,622 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 550 462 1 3
OMEPRAZOLE 541 382 2 2
FUROSEMIDE 499 432 3 6
AMLODIPINE BESYLATE 469 405 4 4
ATORVASTATIN CALCIUM 445 358 5 12
SERTRALINE HCL 418 341 6 25
WARFARIN SODIUM 398 397 7 15
SIMVASTATIN 392 272 8 1
DONEPEZIL HCL 345 341 9 32
HYDROCODONE-ACETAMINOPHEN 340 208 S3 10 7
CRESTOR 296 207 11 24
LEVOTHYROXINE SODIUM 283 232 12 5
NAMENDA 280 263 13 48
GABAPENTIN 276 187 14 14
LANTUS 255 197 15 51
NEXIUM 252 188 16 22
METOPROLOL TARTRATE 251 193 17 10
METOPROLOL SUCCINATE 250 190 18 13
MIRTAZAPINE 230 227 19 46
CARVEDILOL 207 182 20 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 132 21 20
CLOPIDOGREL 191 156 22 37
POTASSIUM CHLORIDE 186 150 23 16
DIVALPROEX SODIUM 173 141 24 91
FENTANYL 168 133 S2 25 87
MELOXICAM 154 106 26 28
TAMSULOSIN HCL 142 117 27 33
HYDROCHLOROTHIAZIDE 141 114 28 9
OXYCODONE-ACETAMINOPHEN 140 64 S2 29 60
LIPITOR 135 116 30 83
ZOLPIDEM TARTRATE 135 61 30 17
HYDRALAZINE HCL 134 119 32 84
TRAMADOL HCL 133 118 33 18
PANTOPRAZOLE SODIUM 132 96 34 39
LEVOFLOXACIN 126 97 35 99
ISOSORBIDE MONONITRATE ER 123 120 36 50
METFORMIN HCL 123 83 36 8
PRAVASTATIN SODIUM 120 100 38 11
KLOR-CON M20 120 119 38 68
FLUOXETINE HCL 117 59 40 59
PROMETHAZINE HCL 117 62 R 40 70
LACTULOSE 113 81 42 125
ATENOLOL 111 88 43 23
PLAVIX 110 88 44 58
NIASPAN 110 89 44 103
LOSARTAN POTASSIUM 109 91 46 21
AMITRIPTYLINE HCL 105 49 R 47 61
ALLOPURINOL 102 87 48 29
NOVOLOG 102 81 48 98
ROPINIROLE HCL 101 85 50 92
DIOVAN 101 82 50 53
ADVAIR DISKUS 100 75 52 45
TOPIRAMATE 99 26 53 155
FENOFIBRATE 99 67 53 57
ACTOS 99 45 53 108
AMOX TR-POTASSIUM CLAVULANATE 96 88 56 126
PROAIR HFA 95 72 57 43
LUMIGAN 93 71 58 315
FLUTICASONE PROPIONATE 92 51 59 30
KLOR-CON M10 91 80 60 132
CARISOPRODOL 91 0 R 60 111
BACLOFEN 91 47 60 137
IPRATROPIUM-ALBUTEROL 89 85 63 131
RESTASIS 88 88 64 233
HALOPERIDOL 87 86 65 176
CITALOPRAM HBR 86 81 66 19
GENERLAC 86 79 66 214
RISPERIDONE 86 74 66 73
CLONIDINE HCL 85 67 69 54
GLIPIZIDE 84 51 70 62
GLIMEPIRIDE 84 80 70 31
JANUVIA 81 56 72 80
NOVOLOG MIX 70-30 80 80 73 261
TRAZODONE HCL 80 60 73 38
EXFORGE 78 41 75 240
LATANOPROST 77 74 76 194
QUETIAPINE FUMARATE 75 57 77 88
ALBUTEROL SULFATE 74 73 78 167
LEVETIRACETAM 73 59 79 109
CIPROFLOXACIN HCL 71 62 80 69
ALENDRONATE SODIUM 71 62 80 36
ENDOCET 70 37 S2 82 106
PREDNISONE 70 54 82 41
ONGLYZA 69 52 84 216
SPIRIVA 67 52 85 49
ALPHAGAN P 67 67 85 448
AVELOX 66 58 87 271
PHENYTOIN SODIUM EXTENDED 65 49 88 142
ESCITALOPRAM OXALATE 65 54 88 75
OXYBUTYNIN CHLORIDE ER 63 62 90 148
MORPHINE SULFATE ER 63 37 S2 90 124
ERYTHROMYCIN 62 60 92 371
BUPROPION XL 62 18 92 170
NYSTATIN 60 51 94 160
ACETAMINOPHEN-CODEINE 60 60 S3 94 206
METHADONE HCL 59 0 S2 96 152
TRAMADOL HCL-ACETAMINOPHEN 59 56 96 180
IBUPROFEN 59 44 96 105
EXELON 57 46 99 119
LIDODERM 57 44 99 162
ZETIA 57 57 99 78
DIVALPROEX SODIUM ER 56 56 102 189
CYMBALTA 56 18 102 44
RANITIDINE HCL 56 31 102 40
NOVOLIN R 55 50 105 149
FAMOTIDINE 55 43 105 96
ENALAPRIL MALEATE 55 33 105 64
AZITHROMYCIN 54 47 108 47
LYRICA 54 45 108 90
METOCLOPRAMIDE HCL 54 41 108 127
DILTIAZEM 24HR CD 54 48 108 82
PHENYTOIN 53 48 112 310
SEROQUEL 52 36 113 168
PIOGLITAZONE HCL 52 33 R 113 259
LOSARTAN-HYDROCHLOROTHIAZIDE 50 40 115 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.